Which lung surgery leaves patients breathing easier? new study aims to find out

NCT ID NCT07477158

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares how patients feel after two minimally invasive surgeries for early-stage lung cancer: segmentectomy (removing a small part of the lung) and lobectomy (removing a whole lobe). Researchers will track shortness of breath, physical function, and quality of life for one year after surgery. 180 participants will answer questionnaires before surgery and at several follow-up points. The goal is to see which procedure leads to better breathing and well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
minimally invasive lung surgery (segmentectomy or lobectomy via VATS or RATS)
What this could lead to
If it works, this could help doctors choose the surgery that gives patients less shortness of breath and better quality of life after lung cancer treatment.
What could go wrong
This is an observational study, not a treatment trial. It only measures outcomes after standard surgery, so it won't test a new drug or cure. Results may not apply to all lung cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario Ramón y Cajal

    RECRUITING

    Madrid, Madrid, 28034, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.